Recent Half-life of sulfonylureas in HNF1A and HNF4A human MODY patients is not prolonged as suggested by the mouse Hnf1a-/- model.
Current pharmaceutical design 2015 Oct .
Urbanová Jana, And?l Michal, Poto?ková Jana, Klíma Josef, Macek Jan, Ptá?ek Pavel, Ma'oška Václav, Kumštý?ová Tereza, Heneberg Pe
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: